PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.177
https://www.valueinhealthjournal.com/article/S1098-3015(20)32433-5/fulltext
Title :
PCN40 Healthcare Resource Utilization in Patients Treated with Encorafenib PLUS Binimetinib for BRAF-Mutant Metastatic Melanoma: DATA from Columbus, a Phase 3 Trial in BRAF-Mutant Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32433-5&doi=10.1016/j.jval.2020.08.177
First page :
Section Title :
Open access? :
No
Section Order :
10133